Cellectis Ownership | Who Owns Cellectis?
Cellectis Ownership Summary
Cellectis is owned by 4.03% institutional investors, and 95.97% retail investors. Long focus capital management is the largest institutional shareholder, holding 4.11% of CLLS shares. American Funds SMALLCAP World A is the top mutual fund, with 1.85% of its assets in Cellectis shares.
CLLS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Cellectis | 4.03% | - | 95.97% |
| Sector | Healthcare Stocks | 232.63% | 10.66% | -143.29% |
| Industry | Biotech Stocks | 382.12% | 10.42% | -292.54% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Long focus capital management | 4.12M | 4.11% | $11.75M |
| B group | 3.28M | 3.27% | $9.35M |
| Ubs asset management americas | 3.18M | 3.17% | $15.38M |
| Millennium management | 534.55K | 0.53% | $962.19K |
| Blackrock funding, inc. /de | 384.30K | 0.38% | $1.86M |
| Morgan stanley | 87.18K | 0.09% | $421.93K |
| Lpl financial | 84.79K | 0.08% | $410.39K |
| Ubs group | 50.10K | 0.05% | $242.48K |
| Bnp paribas arbitrage, snc | 41.30K | 0.04% | $199.89K |
| First affirmative financial network | 25.86K | 0.03% | $46.55K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| B group | 3.28M | 6.88% | $9.35M |
| Long focus capital management | 4.12M | 0.39% | $11.75M |
| Delaney dennis r | 24.00K | 0.03% | $68.40K |
| First affirmative financial network | 25.86K | 0.03% | $46.55K |
| Virtu financial | 25.21K | 0.00% | $72.00K |
| Ubs asset management americas | 3.18M | 0.00% | $15.38M |
| Pom investment strategies | 495.00 | 0.00% | $1.41K |
| Global retirement partners | 7.04K | 0.00% | $34.06K |
| Millennium management | 534.55K | 0.00% | $962.19K |
| Harbour investments | 4.50K | 0.00% | $21.78K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs asset management americas | 3.18M | 0.00% | 3.18M |
| Millennium management | 534.55K | 0.00% | 534.55K |
| Blackrock funding, inc. /de | 384.30K | - | 384.30K |
| Virtu financial | 25.21K | 0.00% | 25.21K |
| B group | 3.28M | 6.88% | 25.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital investors | - | - | -1.85M |
| Long focus capital management | 4.12M | 0.39% | -594.03K |
| Principal financial group | - | - | -411.80K |
| Macquarie group | - | - | -226.88K |
| Kbc group nv | - | - | -163.45K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Millennium management | 534.55K | 0.00% | 534.55K | $962.19K |
| Blackrock funding, inc. /de | 384.30K | - | 384.30K | $1.86M |
| Virtu financial | 25.21K | 0.00% | 25.21K | $72.00K |
| Delaney dennis r | 24.00K | 0.03% | 24.00K | $68.40K |
| Marshall wace, llp | 10.44K | - | 10.44K | $29.74K |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -1.00 |
| Toronto dominion bank | -31.00 |
| Frg family wealth advisors | -80.00 |
| Qube research | -112.00 |
| Principal securities | -179.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 20 | -31.03% | 4,043,805 | -51.35% | 4 | 5.87% | 13 | - | 2 | -66.67% |
| Sep 30, 2025 | 27 | 17.39% | 8,300,546 | -29.28% | 8 | 6.04% | 13 | 62.50% | 5 | -28.57% |
| Jun 30, 2025 | 22 | -18.52% | 11,737,843 | -13.71% | 11 | 6.33% | 7 | -22.22% | 7 | -12.50% |
| Mar 31, 2025 | 27 | -12.90% | 13,602,212 | 6.61% | 13 | 8.36% | 9 | -25.00% | 8 | 33.33% |
| Dec 31, 2024 | 20 | -31.03% | 5,664,103 | -42.00% | 5 | 5.94% | 8 | 33.33% | 5 | -28.57% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| American Funds SMALLCAP World A | 1.85M | 1.85% | - |
| UBS (Lux) Digital Health Equity SB USD | 1.44M | 1.44% | - |
| UBS Lux Dgtl Hlth Eq Fd seeding P acc | 1.30M | 1.30% | - |
| iShares Biotechnology ETF | 349.76K | 0.35% | 349.76K |
| Principal U.S. Small Cap Equity | 289.60K | 0.29% | -4.40K |
| Delaware Healthcare I | 226.88K | 0.23% | - |
| Macquarie Healthcare I | 226.88K | 0.23% | - |
| Nomura Healthcare Fund Class I | 226.88K | 0.23% | - |
| Galileo - Biotech Innovation Fund S USD | 226.07K | 0.22% | - |
| Principal SmallCap R5 | 199.15K | 0.20% | -90.45K |
CLLS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools